The population structure of Staphylococcus aureus in China and Europe assessed by multiple-locus variable number tandem repeat analysis;: Clues to geographical origins of emergence and dissemination by Yan, X. et al.
  
 University of Groningen
The population structure of Staphylococcus aureus in China and Europe assessed by
multiple-locus variable number tandem repeat analysis;
Yan, X.; Schouls, L. M.; Pluister, G. N.; Tao, X.; Yu, X.; Yin, J.; Song, Y.; Hu, S.; Luo, F.; Hu,
W.
Published in:
Clinical Microbiology and Infection
DOI:
10.1016/j.cmi.2015.08.022
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2016
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Yan, X., Schouls, L. M., Pluister, G. N., Tao, X., Yu, X., Yin, J., ... Grundmann, H. (2016). The population
structure of Staphylococcus aureus in China and Europe assessed by multiple-locus variable number
tandem repeat analysis; Clues to geographical origins of emergence and dissemination. Clinical
Microbiology and Infection, 22(1), 60.e1–60.e8. https://doi.org/10.1016/j.cmi.2015.08.022
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 21-05-2020
ORIGINAL ARTICLE BACTERIOLOGYThe population structure of Staphylococcus aureus in China and Europe
assessed by multiple-locus variable number tandem repeat analysis; clues
to geographical origins of emergence and disseminationX. Yan1,2,3, L. M. Schouls4, G. N. Pluister4, X. Tao1,3, X. Yu5, J. Yin5, Y. Song6, S. Hu7, F. Luo6, W. Hu7, L. He1,3,
F. Meng1,3, T. Donker2, E. Tsompanidou2, J. M. van Dijl2, J. Zhang1,3 and H. Grundmann2
1) State Key Laboratory of Infectious Disease Prevention and Control, National Institute for Communicable Disease Control and Prevention, Chinese Center for
Disease Control and Prevention, Beijing, China, 2) Department of Medical Microbiology, University of Groningen, University Medical Centre Groningen,
Rijksuniversiteit Groningen, The Netherlands, 3) Collaborative Innovation Centre for Diagnosis and Treatment of Infectious Diseases, Hangzhou, China, 4) National
Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands, 5) Heilongjiang Provincial Centre for Disease Control and Prevention
Harbin, 6) Chaoyang Centre for Disease Control and Prevention, Beijing and 7) Anhui Provincial Centre for Disease Control and Prevention, Hefei, ChinaAbstractTo compare the genetic population structure of Staphylococcus aureus from China and Europe, 1294 human isolates were characterized by
multiple-locus variable number tandem repeat analysis (MLVA). In total, MLVA identified 17 MLVA complexes (MCs), comprising 260 MLVA
types (MTs) among the Chinese isolates and 372 MTs among the European isolates. The five most frequent MCs among the Chinese isolates
belonged to MC398, MC5 subclade a, MC8, MC437 and MC7 and made up 55% of the sample. For the European isolates, the five most
frequent MCs consisted of MC5 subclade a, MC45, MC8, MC30 and MC22, which accounted for 64% of the sample. Phylogeographic
analysis of the major MCs shared between China and Europe points to a European origin of MC8 but cannot provide a consistent signal
for MC5 subclade a, probably indicating a different origin. Diversity and frequency distributions of other lineages were also compared.
Altogether, this study provides the first snapshot of two extant populations of S. aureus from Europe and China, and important clues on
the emergence and dissemination of different lineages of S. aureus.
Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All
rights reserved.
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p://dx.doi.org/10.1016/j.cmi.2015.08.022IntroductionStaphylococcus aureus is a well-known pathogen because of its
high virulence potential and its capability of colonizing both
humans and domesticated animals. It is the most frequent cause
of purulent skin and soft-tissue infections in humans, but it also
has the potential to cause life-threatening bloodstream in-
fections, endocarditis, toxic shock syndrome and necrotizing
pneumonia. Compared with other bacterial species, the evo-
lution of S. aureus is rather clonal [1]. Most isolates of S. aureus
can be grouped into a limited number of clonal lineages orious Diseases. Published by Elsevier Ltd. All rights reserved
CMI Yan et al. S. aureus in China and Europe 60.e2complexes, each of which is defined by highly related core
genomes and a unique combination of core variable genes.
Whole-genome sequences of S. aureus strains reveal that core
genes, which exist in all isolates, are highly conserved (97%) and
diversify at the level of clonal complexes mainly by the accu-
mulation of single nucleotide substitutions [2–4]. Therefore, it
is possible to unequivocally discern most lineages by different
molecular typing approaches.
As much attention focused on the emergence and spread of
methicillin-resistant S. aureus (MRSA), which has become a
frequent source of difficult-to-treat hospital-acquired (HA) and
community-acquired (CA) infections, most of the available
strain collections are biased towards MRSA and very few
meaningful conclusions can be inferred about natural pop-
ulations of methicillin-susceptible S. aureus (MSSA) from which
MRSA lineages happen to emerge. The present study therefore
aimed to describe the genetic structure of large S. aureus
population samples collected at multiple sites in China and
Europe using comprehensive sampling frames that reflect the
natural diversity of S. aureus.Materials and MethodsTABLE 2. Overview of 647 European Staphylococcus aureus








Patients Austria 49 35 (8.3) 14 (6.2)
Belgium 25 3 (0.7) 22 (9.7)
Bulgaria 14 6 (1.4) 8 (3.5)
Croatia 17 12 (2.9) 5 (2.2)
Cyprus 2 2 (0.5) 0 (0.0)Bacterial isolates
In order to gather a representative sample of the S. aureus
population, 1294 S. aureus isolates were included in the study.
Of these isolates, 647 were collected in China during the years
2005–2011, and comprised 253 clinical and 394 healthy car-
riage isolates (85.5% MSSA, 14.5% MRSA) (Table 1). Isolates
from patients were collected from two hospitals in eastern
China, and healthy carriage isolates originated from 1530 and
918 nose swabs that were sampled at health centres in Beijing
and Harbin, respectively. For comparison, an equivalent num-
ber of European S. aureus isolates (n = 647, 64.9% MSSA, 35.1%
MRSA) were randomly selected from the European survey
database of isolates from the Staphylococcal Reference Labo-
ratory collected in 2006 and 2007 in 25 countries (Table 2) [5].TABLE 1. Overview of 647 Chinese Staphylococcus aureus
isolates collected from various locations and sources
between 2005 and 2011
Isolate source Province No. of isolates No. of MSSA No. of MRSA
Patients Anhui 190 133 57
Zhejiang 63 32 31
Healthy carriers Heilongjiang 188 183 5
Beijing 206 205 1
Total 647 553 94
Abbreviations: MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-
susceptible S. aureus.
Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology andNasal swabs from healthy carriers were enriched in tryptic
soy broth (OXOID, Basingstoke, UK) with 7% NaCl at 37°C
for 24 h, and then plated onto mannitol salt agar (OXOID).
Plates were incubated at 37°C for 24 h. Presumptive S. aureus
colonies were identified by coagulase production using the
Slidex Staph Plus kit (Murex Biotech Ltd., Dartford, UK), and
confirmed as S. aureus by nuc PCR [6]. The presence of the
mecA gene was used to define MRSA [6]. The clinical isolates
were obtained from diagnostic hospital laboratories and were
also subjected to nuc and mecA PCR for confirmation purposes.
Genetic characterization of isolates
MLVA typing was performed as described by Schouls et al. [7].
All of the isolates were characterized using spa typing and
representative isolates of MLVA types (MT) were subjected to
multilocus sequence typing for the assignment of clonal com-
plexes (CC) [8,9].
The Panton–Valentine leukocidin genes (lukS-PV and lukF-
PV) were detected by PCR as previously described [10].
Data analysis
Minimum spanning trees were used to illustrate the genetic
relationships (BIONUMERICS, beta version 3.5; Applied Maths,
Kortrijk, Belgium). For assignment of MLVA complexes, the
entire in-house MLVA-type database (available at www.mlva.
net) was interrogated. The MTs were grouped if they differed
by no more than a single variable number tandem repeat
whereby the MT with the largest number of single locus vari-
ants (SLVs) was regarded as the founder. Groups of four orCzech Republic 45 28 (6.7) 17 (7.5)
Denmark 25 25 (5.9) 0 (0.0)
Finland 11 7 (1.7) 4 (1.8)
France 71 35 (8.3) 36 (15.9)
Germany 47 26 (6.2) 21 (9.3)
Greece 3 1 (0.2) 2 (0.9)
Hungary 9 8 (1.9) 1 (0.4)
Iceland 1 1 (0.2) 0 (0.0)
Ireland 57 29 (6.9) 28 (12.3)
Italy 37 21 (5.0) 16 (7.1)
Netherlands 54 51 (12.1) 3 (1.3)
Norway 20 20 (4.8) 0 (0.0)
Poland 44 36 (8.6) 8 (3.6)
Portugal 32 18 (4.3) 14 (6.2)
Slovenia 22 19 (4.5) 3 (1.3)
Spain 62 37 (8.8) 25 (11.0)
Total 647 420 (100.0) 227 (100.0)
Abbreviations: MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-
susceptible S. aureus.
Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 22, 60.e1–60.e8
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squared statistics (SPSS, SPSS Inc., Chicago, IL, USA) were
used to test for differences in proportions. A p-value of 0.05
was considered statistically significant. MLVA types within
clonal complexes that have the largest numbers of variants
were defined as founders. Distance to founder in MC8 and MC
subclade 5a between Chinese and European isolates was
calculated by the number of isolates that differ from a founder
by one locus (i.e. SLVs), two (double locus variants, DLV), three
(triple locus variants, TLV), etc.
RIDOM EPICOMPARE software version 1.0 (Ridom GmbH,
Wϋrzburg, Germany) was used to calculate the discriminatory
power at the MLVA level in each MC. The discriminatory po-
wer was estimated by Simpson’s index of diversity, expressing
the probability that two unrelated and different isolates sampled
from the test population would be grouped into different
subtypes by a specific typing method. Non-overlapping CI were
regarded as representing statistically significant differences in
discriminatory power.ResultsThe MLVA identified 260 MTs and 372 MTs among the Chinese
and European isolates, respectively. Both Chinese and Euro-
pean isolates were clustered into 17 distinct MCs (Fig. 1). There
was a systematic difference in the distribution of these S. aureus
complexes between China and Europe (Fig. 1, Table 3).
Eight MLVA complexes had significantly more Chinese iso-
lates. These were MC1, MC5 subclade b, MC7, MC123,
MC398, MC437, MC621 and MC1933. In contrast, isolates
from European patients were dominant in other MCs, namely
MC2, MC5 subclade a, MC22, MC30 and MC45. The five most
frequent MCs among the Chinese isolates were MC398, MC5
subclade a, MC8, MC437 and MC7, which made up 55.0% of
the Chinese sample. For the European isolates, the five most
frequent MCs were MC5 subclade a, MC45, MC8, MC30 and
MC22, which accounted for 64.3% of the sample. Hence the
five most frequent complexes in China and in Europe had only
MC8 and MC5 subclade a in common, which together also
contained most of the MRSA (62%) in the entire collection.
Sixty-six per cent of all MC8 isolates, and 49% of all MC5
subclade a were MRSA (Table 3). Distances to founder in MC8
and MC5 subclade a were compared between Chinese and
European isolates (Table 4). Fig. 2 offers a detailed view of the
tree structure of MC8 and MC5. In MC8, the majority of Eu-
ropean variants occupy a central position and either belong to
the founder MLVA type or are SLVs and DLVs of the founder,
whereas Chinese isolates are DLVs and TLVs and do not have
founder MLVA types. European isolates also occupy many moreClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectbranches indicating a higher diversity than Chinese isolates (see
Supplementary material, Table S2). The distributions of Chinese
and European variants of MC5 subclone a are very similar in
terms of branch length, branch distribution and distance to
founder. Also there is an equal degree of genetic diversity be-
tween isolates from both origins.
The remaining MRSA isolates from China and Europe—not
belonging to either MC8 and MC5 subclade a—were widely
distributed over 22 MTs and 93 MTs, respectively (Fig. S1A, C),
but two MCs contained significantly more MRSA than others.
These were MC2 and MC22. MC2 consisted of only MRSA and
all of the isolates originated from Europe. Also all of the MRSA
isolates within complex MC22 (80%) were from Europe. A list
of the top five MCs of MSSA and MRSA isolates and the cor-
responding multilocus sequence typing and spa types is pro-
vided in the Supplementary material (Tables S1a (MSSA) and
S1b (MRSA)).
A comparison of the genetic diversity shows that Chinese
isolates and European isolates do not differ at the level of in-
dividual MCs except for MC8 (see Supplementary material,
Table S2). The same applies to Chinese clinical and Chinese
carriage isolates if only MCs that contain more than ten isolates
are considered.
The presence of pvl genes was determined for all the Chi-
nese isolates. Thirty-eight isolates (5.9%) were pvl positive,
which include five MRSA and 33 MSSA isolates. The majority of
isolates belonging to MC5 subclade b/CC88 (70%) were pvl
positive.DiscussionOur present study represents the first attempt to describe two
extant populations of S. aureus from opposite ends of the same
continental shelf—China and Europe. Using MLVA as a typing
method for isolates obtained through dedicated surveys, we
found a systematic difference in the distribution of S. aureus
clonal lineages between Europe and China. This difference was
particularly pronounced for four international lineages (MC2,
MC22, MC30 and MC45) that are dominant in Europe and also
include successful lineages of hospital-acquired (HA-)MRSA
(MC2 and MC22). Compared with the European isolates, eight
MLVA complexes (MC1, MC7, MC123, MC398, MC437,
MC621, MC1933 and MC5 subclade b) were found to be
dominant among the Chinese isolates. The comparison with the
European isolates suggests that the Chinese sample consists of a
combination of pandemic lineages and a considerable number of
local clones. MC8/ST239/CC8 and MC5/ST5/CC5 are clear
representatives of pandemic MRSA lineages in China, which
were also shown in previous studies [11]. Both lineages are alsoious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 22, 60.e1–60.e8
FIG. 1. Minimum spanning tree of Staphylococcus aureus isolates from China and Europe based on the relatedness between multiple-locus variable
number tandem repeat analysis (MLVA) types. Each circle represents a single MLVA type, and the size of the circle indicates the number of isolates with
the same MLVA type. Geographical origin (China or Europe) is indicated by red or green segments respectively. MLVA complexes are shown by
coloured halos.
CMI Yan et al. S. aureus in China and Europe 60.e4widely prevalent in Europe [12] and contained the majority of
MRSA of the present sample.
It should be noted that there are clear limitations to this
study, mainly due to unequal sampling. The Chinese S. aureus
sample was obtained from two source populations, whereby
the majority of isolates (n = 394) were from healthy carriers
while only 253 were clinical isolates. This is in stark contrast to
the European sample, which was entirely made up of clinical
isolates. Moreover, the sampling frame used for the European
collection deliberately enriched for MRSA [5]. This explains the
larger proportion of MRSA in the European sample and could
account for a degree of overrepresentation of MCs that typi-
cally include MRSA. A recent study carried out among healthy
carriers in nine European nations revealed a frequency distri-
bution of the main lineages among MSSA and MRSA that was
almost indistinguishable from the frequency distribution of the
European sample used in our present study [13]. It can there-
fore be assumed that the spectrum and diversity of MRSA and
MSSA reflect the natural distribution of lineages in EuropeClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology anddespite the enrichment of nosocomial MRSA in the European
sample.
We also argue that clinical samples are representative of
carriage isolates as it has been shown that most of the patients,
who developed S. aureus infection after admission to a hospital,
were infected by their own colonizing strains [14]. However,
carriage isolates recovered from hospital patients may differ
from carriage isolates in healthy carriers from the community,
as the former have had more exposure to health care and
antibiotic treatment and are therefore more likely—over
time—to acquire and carry typical hospital-associated strains.
Indeed we found that Chinese clinical isolates were more likely
to be MRSA and clustered among different MLVA types than
isolates recovered from healthy carriers in the community (see
Supplementary material, Fig. S1). This differential distribution
cannot be investigated for European isolates, which were all
from infected patients.
Another incongruence that deserves consideration relates to
the geodemographic representativeness of the samples used inInfectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 22, 60.e1–60.e8
TABLE 3. Distribution of MLVA complexes (MCs) of methicillin-sensitive and methicillin-resistant Staphylococcus aureus by China
and Europe






pChina Europe China Europe China Europe
1 1 38 (6.9) 10 (2.4) 0.001 3 (3.2) 0 0.025 41 (6.3) 10 (1.5) <0.0001
2 5 0 0 – 0 28 (12.3) <0.0001 0 28 (4.3) <0.0001
5a 5 58 (10.5) 37 (8.8) 0.445 20 (21.3) 72 (31.7) 0.077 78 (12.1) 109 (16.9) 0.018
5b 88 20 (3.6) 0 <0.0001 0 0 – 20 (3.1) 0 <0.0001
7 7 52 (9.4) 28 (6.7) 0.128 1 (1.1) 0 0.293 53 (8.2) 28 (4.3) 0.006
8 8 22 (4.0) 33 (7.9) 0.011 52 (55.3) 54 (23.8) <0.0001 74 (11.4) 87 (13.4) 0.312
15 15 24 (4.3) 33 (7.9) 0.027 0 0 – 24 (3.7) 33 (5.1) 0.278
22 22 2 (0.4) 10 (2.4) 0.006 0 39 (17.2) <0.0001 2 (0.3) 49 (7.6) <0.0001
30 30 2 (0.4) 78 (18.6) <0.0001 0 2 (0.9) 1 2 (0.3) 80 (12.4) <0.0001
45 45 1 (0.2) 73 (17.4) <0.0001 1 (1.1) 17 (7.5) 0.029 2 (0.3) 90 (13.9) <0.0001
123 121 21 (3.8) 5 (1.2) 0.015 0 0 – 21 (3.3) 5 (0.8) 0.002
398 398 89 (16.1) 1 (0.2) <0.0001 3 (3.2) 0 0.025 92 (14.2) 1 (0.1) <0.0001
437 1 59 (10.7) 2 (0.5) <0.0001 0 0 – 59 (9.1) 2 (0.3) <0.0001
482 8 5 (1.0) 9 (2.1) 0.172 2 (2.1) 2 (0.9) 0.583 7 (1.1) 11 (1.7) 0.478
621 59 35 (6.3) 3 (0.7) <0.0001 6 (6.4) 1 (0.4) 0.003 41 (6.3) 4 (0.6) <0.0001
674 25 29 (5.2) 19 (4.5) 0.656 0 0 – 29 (4.5) 19 (2.9) 0.185
897 20 12 (2.2) 4 (0.9) 0.203 0 0 – 12 (1.8) 4 (0.6) 0.075
1933 ST6a 34 (6.2) 0 <0.0001 0 0 – 34 (5.3) 0 <0.0001
None 50 (9.0) 75 (17.9) – 6 (6.4) 12 (5.3) – 56 (8.7) 87 (13.4) –
Total 553 (100.0) 420 (100.0) – 94 (100.0) 227 (100.0) – 647 (100.0) 647 (100.0) –
Abbreviations: MLVA, multiple-locus variable number tandem repeat analysis; MRSA, methicillin-resistant Staphylococcus aureus; MSSA, methicillin-susceptible S. aureus.
aST6 is a double locus variant (DLV) of ST5.
60.e5 Clinical Microbiology and Infection, Volume 22 Number 1, January 2016 CMIthis study. The Chinese isolates were collected in far fewer
locations than the European isolates (Tables 1 and 2). However,
healthy carriers sampled in Beijing were from 31 of the 34
provincial level divisions of China and included, apart from
ethnic Han Chinese, also individuals from 16 of the 55 other
ethnic minorities in China. This shows that the population
snapshot from Beijing was hardly local, but rather representa-
tive of a much larger geographical region. Furthermore, a
recent study on the diversity of S. aureus bacteraemia isolates
from 16 hospitals in 12 cities in China showed a similar dis-
tribution of lineages, whereby ST239 and ST5 were the main
MRSA genotypes, while CC7, CC188, CC5 and CC398 were
the dominant MSSA genotypes [15]. We therefore believe that
the results of our present study were not biased to the extentTABLE 4. Frequencies of n-locus-variants in MLVA complex
(MC) subclade 5a and MC8 isolates from Europe and China









Founder 5 (1) 8 (1) 15 (1) –
One locus different
from founder
29 (12) 34 (10) 37 (9) 5 (1)
Two loci different
from founder
48 (22) 18 (11) 17 (13) 10 (5)
Three loci different
from founder
21 (12) 17 (10) 11 (8) 46 (6)
Four loci different
from founder
6 (4) 1 (6) 7 (4) 4 (2)
Five loci different from
founder
– – 9 (2)
Total no. isolates 109 78 87 74
Abbreviations: MLVA, multiple-locus variable number tandem repeat analysis.
Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectthat it would invalidate the overall conclusions, which can
highlight the differences in the distribution of major clonal lin-
eages in China and Europe.
The analysis of the distances to founder in MC8 showed the
majority of European variants are SLVs and DLVs of the
founder, whereas more Chinese variants are DLVs and TLVs.
MLVA diversity in MC8 was also markedly higher in Europe
than in China. The higher diversity is an indication of longer
evolutionary time spans during which lineages had time to
diversify locally while limited diversity indicated recent
introduction. Hence our results point to a European origin of
MC8.
The MC5 subclade a corresponds to CC5, which is a com-
mon and widespread clonal complex. The analysis of the dis-
tances to founder and MLVA diversity suggest that this lineage
may have emerged neither in Europe nor in China. Instead, it
appears to have diversified independently in both locations
along different trajectories caused by geographic segregation.
This hypothesis is supported by investigating the evolutionary
history of ST5-MRSA, which showed that SCCmec acquisition
occurs frequently in local S. aureus populations, whereas the
long-distance geographical spread of MRSA is relatively rare
[16]. MC5 subclade b is a Chinese MSSA clade and most of the
respective isolates are Panton–Valentine leukocidin positive.
Multilocus sequence typing analysis of this clade showed that all
of these isolates belong to two novel sequence types, namely
ST2148 and ST2141, which are both SLVs of ST88 (CC88).
ST88 was reported to prevail over a large geographical area in
Africa and was also frequently isolated in Australia but is
sporadically reported in Europe [17,18].ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 22, 60.e1–60.e8
CMI Yan et al. S. aureus in China and Europe 60.e6MSSA MC398/ST398/CC398 represented the most
frequently identified human colonizer in China, encompassing
16% of all MSSA isolates of the Chinese sample. Consistent with
this observation, ST398/CC398 MSSA strains have also been
reported previously as major causative agents for HA-MSSA
and CA-MSSA infections in China [19,20]. Our own previous
observations also showed that isolates of this lineage are
frequently found among slaughter pigs in the Heilongjiang
province [21]. In Europe, the ST398-MRSA lineage is mainly
associated with livestock, and it is occasionally transmitted to
humans during occupational exposure. It has furthermore been
suggested that livestock-associated-ST398 MRSA is mostly
transmitted among veterinarians and their families rather than
being transmitted in hospitals [22,23]. In contrast, the ST398
MSSA clone found in China seems to be readily transmitted
between humans, both in hospitals and in the community
[19,20]. In the present study, we found two major MTs
belonging to MC398, namely MT565/MC398/ST398/CC398/
t571 and MT569/MC398/ST398/CC398/t034 (Fig. S1B). Inter-
estingly, MT569 isolates were also identified in pigs (data notFIG. 2. Minimum spanning tree dis-
playing the methicillin-resistant
Staphylococcus aureus (MRSA)/methi-
cillin-susceptible S. aureus (MSSA)
distribution among Chinese and
European isolates belonging to MC8
and MC5a. Each circle represents a
single multiple-locus variable number
tandem repeat analysis (MLVA) type,
and the size of the circle indicates the
number of isolates with the same
MLVA type. Resistance characteris-
tics: MRSA versus MSSA are indi-
cated in dark green and yellow
colour code. Note that branches
without nodes indicate MLVA types
that are absent from either the Chi-
nese or European isolates.
Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology andshown), whereas MT565 isolates were so far exclusively iso-
lated from humans. This finding suggests that these two main
subclones of MC398 in China may have become specifically
adapted to different hosts. In this context it is noteworthy that
in recent years an increasing number of ST398/CC398/t571
MSSA infections have been reported in geographically diverse
regions around the globe [24]. It still remains to be seen if these
isolates are monophyletic and represent a public health chal-
lenge in Europe and China.
MC621 was another complex that probably originated from
and disseminated in China. One of the SLVs of MT621/MC621/
ST2147/t437 is MT1035/MC621/ST59/t437. E-burst analysis
showed that ST2147 does not belong to any known clonal
complex. Different lineages occasionally share the same spa
gene indicative of homoplasy within the spa region. MRSA
isolates belonging to ST59/CC59 were previously identified as
the most common type of CA-MRSA in Chinese children with
skin and soft-tissue infections. Importantly, ST59/CC59/t437
was also reported as the predominant CA-MRSA type in other
Asian countries [25], and it was recently identified acrossInfectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 22, 60.e1–60.e8
60.e7 Clinical Microbiology and Infection, Volume 22 Number 1, January 2016 CMIEurope [26]. Whether this predominant CA-MRSA clone has
evolved from MC621/ST2147/t437 still needs to be elucidated.
It remains also to be seen whether the spa type t437 confers
an advantage in terms of transmissibility or tenacity, which
would explain the abundance of this spa type among
community-acquired MRSA in China and its rapid expansion in
Europe [26].
Some lineages, such as MC2, MC22, MC30 and MC45, which
represent successful clones in Europe hardly exist in China.
MC2 is related to the southern German HA-MRSA clone
(ST228/CC5), which was reported in southern Germany and
Italy in the mid-1990s [27,28], and which has spread through
the Alpine, Balkan and Appenine regions in recent years [18].
MC22/ST22/CC22 is the most successful European MRSA
clone. One reason for its apparent absence from China could
be that MC22/ST22/CC22 has not yet had sufficient time to
diffuse in China as it did in Europe, where it emerged as
EMRSA-15 in the late 1980s in the UK [2]. Furthermore, MC30/
CC30 and MC45/CC45 were only found in the European
sample. This finding is in accordance with previous studies,
where the two complexes were confined to Europe and the
USA [29].
In conclusion, the present study provides novel hypotheses
about the geographical origins of emergence and events leading
to the dissemination of clonal lineages of S. aureus with
particular public health importance in China and Europe. As
such, the results will serve as leads for future studies to better
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